134 related articles for article (PubMed ID: 35462530)
1. Capecitabine-induced severe diabetes and hypokalemia: a case report.
Yang Q; Chen C; Ran J
J Med Case Rep; 2022 Apr; 16(1):163. PubMed ID: 35462530
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridemia and hyperglycemia induced by capecitabine: a report of two cases and review of the literature.
Han GH; Huang JX
J Oncol Pharm Pract; 2015 Oct; 21(5):380-3. PubMed ID: 24781450
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine-induced hyperosmolar hyperglycaemic state.
Yim C; Hussein N; Arnason T
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762290
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Smith SM; Anderson SD; Wen S; Gong Y; Turner ST; Cooper-Dehoff RM; Schwartz GL; Bailey K; Chapman A; Hall KL; Feng H; Boerwinkle E; Johnson JA; Gums JG
Pharmacotherapy; 2009 Oct; 29(10):1157-65. PubMed ID: 19792989
[TBL] [Abstract][Full Text] [Related]
5. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
6. A Case Report of Recurrent Hypokalemia During Pregnancies Associated With Nonaldosterone-Mediated Renal Potassium Loss.
Pintavorn P; Munie S
Can J Kidney Health Dis; 2021; 8():20543581211017424. PubMed ID: 34104455
[TBL] [Abstract][Full Text] [Related]
7. Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.
Maillard M; Eche-Gass A; Ung M; Brice A; Marsili S; Montastruc M; Puisset F; Thomas F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):579-583. PubMed ID: 33587160
[TBL] [Abstract][Full Text] [Related]
8. Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature.
Zou Y; Liu S; Wu J; Sun Z
World J Surg Oncol; 2021 Nov; 19(1):332. PubMed ID: 34809643
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine-induced leukoencephalopathy in a patient with triple-negative breast cancer: A case report and review of the literature.
Liu L; Brown EN; Abu-Shahin FI
J Oncol Pharm Pract; 2022 Apr; 28(3):703-709. PubMed ID: 34791927
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer.
Martín M; Makhson A; Gligorov J; Lichinitser M; Lluch A; Semiglazov V; Scotto N; Mitchell L; Tjulandin S
Oncologist; 2012; 17(4):469-75. PubMed ID: 22467666
[TBL] [Abstract][Full Text] [Related]
11. Effects of somatostatin and oral potassium administration on terbutaline-induced hypokalemia.
Schnack C; Podolsky A; Watzke H; Schernthaner G; Burghuber OC
Am Rev Respir Dis; 1989 Jan; 139(1):176-80. PubMed ID: 2563217
[TBL] [Abstract][Full Text] [Related]
12. [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].
Yasaki S; Tukamoto Y; Yuasa N; Ishikawa T; Yoshii F
Rinsho Shinkeigaku; 2012; 52(4):251-6. PubMed ID: 22531658
[TBL] [Abstract][Full Text] [Related]
13. [A case of trastuzumab-resistant breast cancer responding to lapatinib/capecitabine therapy].
Hayashi M; Orita M; Hironaka H; Morita N
Gan To Kagaku Ryoho; 2014 Mar; 41(3):353-5. PubMed ID: 24743282
[TBL] [Abstract][Full Text] [Related]
14. Photosensitive lichenoid skin reaction to capecitabine.
Shah RA; Bennett DD; Burkard ME
BMC Cancer; 2017 Dec; 17(1):866. PubMed ID: 29258457
[TBL] [Abstract][Full Text] [Related]
15. Severe hypokalemia with cardiac arrest as an unusual manifestation of alcoholism.
Abdulfattah O; Rahman EU; Alnafoosi Z; Schmidt F
J Community Hosp Intern Med Perspect; 2018; 8(5):285-291. PubMed ID: 30357049
[No Abstract] [Full Text] [Related]
16. Walking hyponatremia syndrome of inappropriate antidiuretic hormone secretion secondary to carbamazepine use: a case report.
Palacios Argueta PJ; Sánchez Rosenberg GF; Pineda A
J Med Case Rep; 2018 Jul; 12(1):202. PubMed ID: 29991348
[TBL] [Abstract][Full Text] [Related]
17. [A case of lacrimal duct obstruction caused by capecitabine].
Noguchi Y; Mitani T; Kawara H; Tokuyama Y; Tamura Y; Uchiyama K; Shimizu Y
Gan To Kagaku Ryoho; 2015 Jan; 42(1):123-5. PubMed ID: 25596694
[TBL] [Abstract][Full Text] [Related]
18. [A case of severe hypokalemia caused by a Chinese herbal remedy (Yokukansan) in an 81-year-old woman with dementia].
Nishiyama N; Takeshita M; Tanaka K; Miyao M; Mizuno Y
Nihon Ronen Igakkai Zasshi; 2011; 48(5):553-7. PubMed ID: 22323035
[TBL] [Abstract][Full Text] [Related]
19. Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes.
Kang MY
Korean J Intern Med; 2015 Sep; 30(5):648-56. PubMed ID: 26354059
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine.
Botticelli A; Scagnoli S; Roberto M; Lionetto L; Cerbelli B; Simmaco M; Marchetti P
J Oncol Pharm Pract; 2020 Dec; 26(8):1836-1842. PubMed ID: 32131682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
